Neurodevelopmental Outcomes at 42 Months After Thyroxine Supplementation in Infants Below 28 Weeks' Gestation: A Randomized Controlled Trial

Background: Infants below 28 weeks' gestation have low thyroid hormone plasma levels compared with more mature infants and this may contribute to their risk of developmental disability. We aimed at determining the effect of supplementation with levothyroxine (LT4) for extremely premature infant...

Descripción completa

Detalles Bibliográficos
Autores principales: Ng, Sze May, Turner, Mark A., Weindling, A. Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2020
Materias:
Original Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7374616/
https://www.ncbi.nlm.nih.gov/pubmed/32070246
http://dx.doi.org/10.1089/thy.2019.0293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7374616/
https://www.ncbi.nlm.nih.gov/pubmed/32070246
http://dx.doi.org/10.1089/thy.2019.0293

Ejemplares similares